β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells

Cancer Research

Volumn 71, Issue 7, 2011, Pages 2600-2610

  Josson, Sajni ^a   Nomura, Takeo ^a,b   Lin, Jen Tai ^a   Huang, Wen Chin ^a   Wu, Daqing ^b   Zhau, Haiyen E ^a   Zayzafoon, Majd ^c   Neale Weizmann, M ^b,d   Gururajan, Murali ^a   Chung, Leland W K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HEMOCHROMATOSIS PROTEIN; IRON; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER MORTALITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; IRON BALANCE; KIDNEY CANCER; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SOFT TISSUE METASTASIS;

ANIMALS; BETA 2-MICROGLOBULIN; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IRON; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASMS; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 79953299688     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3382     Document Type: Article

References (40)

1. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655-64.
2. Cunningham BA, Wang JL, Berggard I, Peterson PA. The complete amino acid sequence of beta 2-microglobulin. Biochemistry 1973;12:4811-22.
3. Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, et al. The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 1987;139:3132-38. (Pubitemid 17157490)
4. Pedersen LO, Hansen AS, Olsen AC, Gerwien J, Nissen MH, Buus S. The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigen. Scand J Immunol 1994;39:64-72. (Pubitemid 24232899)
5. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44:959-68. (Pubitemid 16045342)
6. Huang WC, Havel JJ, Zhau HE, Qian WP, Lue HW, Chu CY, et al. Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells. Clin Cancer Res 2008;14:5341-47.
7. Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, et al. beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 2006;66:9108-16. (Pubitemid 44521130)
8. Huang WC, Zhau HE, Chung LW. Androgen receptor survival signaling is blocked by anti-{beta}2-microglobulin monoclonal antibody via a mitogen-activated protein kinase/lipogenic pathway in human prostate cancer cells. J Biol Chem 2010;285:7947-56.
9. Gross M, Top I, Laux I, Katz J, Curran J, Tindell C, et al. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. Clin Cancer Res 2007;13:1979-86. (Pubitemid 46649863)
10. Rowley DR, Dang TD, McBride L, Gerdes MJ, Lu B, Larsen M. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res 1995;55:781-86.
11. Yang J, Qian J, Wezeman M, Wang S, Lin P, Wang M, et al. Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. Cancer Cell 2006;10:295-307. (Pubitemid 44512192)
12. Teasdale C, Mander AM, Fifield R, Keyser JW, Newcombe RG, Hughes LE. Serum beta2-microglobulin in controls and cancer patients. Clin Chim Acta 1977;78:135-43. (Pubitemid 8126837)
13. Hemmingsen L, Skaarup P. Urinary excretion of ten plasma proteins in patients with renal carcinoma. Scand J Urol Nephrol 1977;11:41-46. (Pubitemid 8068163)
14. Shuster J, Gold P, Poulik MD. beta 2-microglogulin levels in cancerous and other disease states. Clin Chim Acta 1976;67:307-13.
15. Ward DG, Nyangoma S, Joy H, Hamilton E, Wei W, Tselepis C, et al. Proteomic profiling of urine for the detection of colon cancer. Proteome Sci 2008;6:19.
16. Zhu Y, Su Y, Cheng T, Chung LW, Shi C. Beta2-microglobulin as a potential factor for the expansion of mesenchymal stem cells. Biotechnol Lett 2009;31:1361-65.
17. Evans DB, Thavarajah M, Kanis JA. Immunoreactivity and proliferative actions of beta 2 microglobulin on human bone-derived cells in vitro. Biochem Biophys Res Commun 1991;175:795-803.
18. Menaa C, Esser E, Sprague SM. Beta2-microglobulin stimulates osteoclast formation. Kidney Int 2008;73:1275-81.
19. Rothenberg BE, Voland JR. beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A 1996;93:1529-34.
20. Muckenthaler MU, Rodrigues P, Macedo MG, Minana B, Brennan K, Cardoso EM, et al. Molecular analysis of iron overload in beta2-microglobulin-deficient mice. Blood Cells Mol Dis 2004;33:125-31. (Pubitemid 39099293)
21. Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95:1472-77. (Pubitemid 28103416)
22. Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, et al. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006;66:1664-73. (Pubitemid 44646357)
23. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994;54:2577-81. (Pubitemid 24173741)
24. Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H, et al. Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res 2006;12:7294-305. (Pubitemid 46095401)
25. Inoue K, Karashima T, Fukata S, Nomura A, Kawada C, Kurabayashi A, et al. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma. Clin Cancer Res 2005;11:6669-77. (Pubitemid 41339008)
26. Thompson EW, Sung V, Lavigne M, Baumann K, Azumi N, Aaron AD, et al. LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis. Clin Exp Metastasis 1999;17:193-204. (Pubitemid 29360897)
27. Bataille R, Magub M, Grenier J, Donnadio D, Sany J. Serum beta-2-microglobulin in multiple myeloma: relation to presenting features and clinical status. Eur J Cancer Clin Oncol 1982;18:59-66. (Pubitemid 12132660)
28. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-29. (Pubitemid 351757205)
29. Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 1993;82:3610-15. (Pubitemid 24006041)
30. Wu D, Zhau HE, Huang WC, Iqbal S, Habib FK, Sartor O, et al. cAMPresponsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 2007;26:5070-77. (Pubitemid 47206947)
31. Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 2005;16:1809-14. (Pubitemid 41790893)
32. Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, et al. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 2006;5:162-70.
33. Balint E, Sprague SM. Beta(2)-microglobulin and bone cell metabolism. Nephrol Dial Transplant 2001;16:1108-11.
34. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-93. (Pubitemid 37328925)
35. Yang J, Zhang X, Wang J, Qian J, Zhang L, Wang M, et al. Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts. Blood 2007;110:3028-35. (Pubitemid 350006957)
36. Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, Fan S, et al. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 2010;9:9.
37. Pani G, Galeotti T, Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010;29:351-79.
38. Semenza GL. Regulation of cancer cell metabolism by hypoxiainducible factor 1. Semin Cancer Biol 2009;19:12-16.
39. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-23. (Pubitemid 28173557)
40. Giatromanolaki A, Harris AL. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 2001;21:4317-24. (Pubitemid 34245369)